Literature DB >> 23462287

NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis.

Fei Zheng1, Shanshan Xing, Zushun Gong, Qichong Xing.   

Abstract

OBJECTIVES: The aim of the present study was to investigate the expression of NLRP3 in aorta of patients with coronary atherosclerosis and to explore the association between aortic expression levels of NLRP3 and atherosclerotic risk factors.
METHODS: We collected small pieces of ascending aorta from 36 patients undergoing coronary artery bypass graft (CABG) surgery, and the arterial tissues from 10 subjects without atherosclerosis through the kidney donation program were taken as control. The expression of NLRP3 of the research and control group was determined by immunohistochemistry. Gensini score was used to evaluate the severity of coronary atherosclerosis.
RESULTS: NLRP3 was strongly expressed in aorta of CABG patients. The aortic NLRP3 expression was elevated in patients with hypertension or diabetes, and smokers. The NLRP3 expression in aorta was positively correlated with total cholesterol, low density lipoprotein cholesterol, and lipoprotein(a) (P<0.05); but negatively correlated with high density lipoprotein cholesterol (P<0.05). Spearman correlation revealed that aortic NLRP3 expression had significant correlation with Gensini coronary severity scores (P<0.05).
CONCLUSIONS: NLRP3 was overexpressed in aorta of patients with coronary atherosclerosis and the aortic NLRP3 expression is correlated with the severity of coronary artery disease and the atherosclerotic risk factors.
Copyright © 2013 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Coronary artery bypass graft; Inflammation; NLRP3; Risk factors

Mesh:

Substances:

Year:  2013        PMID: 23462287     DOI: 10.1016/j.hlc.2013.01.012

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  47 in total

Review 1.  Drivers of age-related inflammation and strategies for healthspan extension.

Authors:  Emily L Goldberg; Vishwa Deep Dixit
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 2.  The NLRP3 inflammasome and stroke.

Authors:  Yeqing Tong; Zhi-Hong Ding; Fa-Xian Zhan; Li Cai; Xiaoxv Yin; Jin-Lian Ling; Jian-Jun Ye; Shuang-Yi Hou; Zuxun Lu; Zhi-Hong Wang; Jia-Fa Liu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients.

Authors:  Altaf Afrasyab; Peng Qu; Yang Zhao; Kuang Peng; Hongyan Wang; Dayuan Lou; Nan Niu; Dajun Yuan
Journal:  Heart Vessels       Date:  2015-08-20       Impact factor: 2.037

Review 4.  Inflammasomes link vascular disease with neuroinflammation and brain disorders.

Authors:  Nikolett Lénárt; David Brough; Ádám Dénes
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-02       Impact factor: 6.200

Review 5.  Aging, inflammation and the environment.

Authors:  Arsun Bektas; Shepherd H Schurman; Ranjan Sen; Luigi Ferrucci
Journal:  Exp Gerontol       Date:  2017-12-21       Impact factor: 4.032

6.  Differential mRNA expression of inflammasome genes NLRP1 and NLRP3 in abdominal aneurysmal and occlusive aortic disease.

Authors:  Carmen Gonzalez-Hidalgo; Joaquin De Haro; Silvia Bleda; Cristina Cañibano; Ignacio Michel; Francisco Acin
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-04

Review 7.  Cytokine Circuits in Cardiovascular Disease.

Authors:  Jesse W Williams; Li-Hao Huang; Gwendalyn J Randolph
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

8.  Regulation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated periodontal disease.

Authors:  Yohei Yamaguchi; Tomoko Kurita-Ochiai; Ryoki Kobayashi; Toshihiko Suzuki; Tomohiro Ando
Journal:  Inflamm Res       Date:  2016-09-24       Impact factor: 4.575

Review 9.  Innate immunity in diabetes and diabetic nephropathy.

Authors:  Jun Wada; Hirofumi Makino
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

Review 10.  Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases.

Authors:  Falguni Baidya; Mariya Bohra; Aishika Datta; Deepaneeta Sarmah; Birva Shah; Priya Jagtap; Swapnil Raut; Ankan Sarkar; Upasna Singh; Kiran Kalia; Anupom Borah; Xin Wang; Kunjan R Dave; Dileep R Yavagal; Pallab Bhattacharya
Journal:  Immunology       Date:  2020-10-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.